Elisa Agostinetto: Patients’ and Physicians’ Perspectives on Brain Imaging Screening in Metastatic Breast Cancer
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post about a paper published in The Breast:
“Out in The Breast Online our survey to physicians and patients on screening for brain metastases in pts with breast cancer
Proud of this international collaboration with colleagues and friends towards better care for pts with brain mets!”
Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X by Elisa Agostinetto, adding:
“Nice work! There is no rationale reason not to screen HER2+ patients for brain metastases.
1) smaller lesions, SRS easier and less radiation necrosis, less morbidity
2) we have two drugs that improve OS in Brain Mets We don’t need RCTs here…”
Title: Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives
Authors: Leonor Matos, Mette van Ramshorst, Volkmar Müller, Elisa Agostinetto, Sabine Linn, Matteo Lambertini, Veronique Dieras, Fanny le Du, Sofia Braga, Carmen Criscitiello, Katarzyna Jerzak, Gil Morgan, Sara Brucker, Patricia von Kroge, Renate Haidinger, Gema Rodríguez Recio, Eva Schumacher-Wulf, Mario Fontes Sousa, Francesco Schettini, Elena Laakmann
You can read the Full Article on The Breast.
More posts featuring Sarah Sammons and Elisa Agostinetto on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023